Omniab Inc Receivables Turnover Ratio (OABI), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Omniab Inc   (NASDAQ: OABI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Omniab Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Omniab Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 4.63, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Omniab Inc in Sep 30 2026 quarter, has decreased to 79 days, compared to 81 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 460 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 2233 to 3251.

What is Receivable Turnover Ratio?
What is Omniab Inc Selling?


What is Receivable Turnover Ratio?





OABI Receivables Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Receivable Change 12.21 % 261.49 % 95.11 % 40.17 % -11.44 %
Y / Y Revenue Change 78.34 % 244.24 % 247.3 % -22.47 % -46.33 %
Receivable Turnover Ratio (TTM) 4.63 4.48 4.41 3.72 4.7
OABI's Total Ranking # 3251 # 2233 # 2896 # 3073 #
Accounts Receivable average collection period days 79 82 83 98 78
Seq. Receivable Change -69.07 % -11.16 % 71.03 % 138.77 % -0.35 %
Seq. Revenue Change -70.23 % -7.01 % 72.24 % 274.1 % -42.55 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 28
Healthcare Sector # 461
Overall Market # 3251

Receivable Turnover Ratio Statistics
High Average Low
0.2 0.1 0.06
(Mar 31 2023)   (Mar 31 2024)






Financial Statements
Omniab Inc 's Accounts Receivable $ 3 Millions Visit OABI's Balance sheet
Omniab Inc 's Sales TTM $ 40 Millions Visit OABI's Income Statement
Sources of OABI's Revenues Visit OABI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OABI's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OABI's Growth Rates OABI's Roa OABI's Inventory Turnover Ratio OABI's Dividend Comparisons
OABI's Profitability Ratios OABI's Roi OABI's Asset Turnover Ratio OABI's Dividend Growth
OABI's Valuation Ratios OABI's Roe OABI's Financial Strength Ratios OABI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Fortrea Holdings Inc   29.58 $ 2,666.700  Millions$ 90.150  Millions
Sonida Senior Living Inc   27.65 $ 638.130  Millions$ 23.076  Millions
Wave Life Sciences Ltd   24.65 $ 87.296  Millions$ 3.541  Millions
Lenz Therapeutics Inc   24.39 $ 12.359  Millions$ 0.507  Millions
Arvinas Inc   20.06 $ 275.300  Millions$ 13.725  Millions
U S Physical Therapy Inc  18.16 $ 837.629  Millions$ 46.137  Millions
Alpha Pro Tech Ltd   17.54 $ 64.940  Millions$ 3.702  Millions
Biogen Inc   15.19 $ 10,297.300  Millions$ 677.900  Millions
Lifestance Health Group Inc   14.89 $ 1,676.889  Millions$ 112.631  Millions
Amneal Pharmaceuticals Inc   14.24 $ 3,196.184  Millions$ 224.488  Millions
Corcept Therapeutics Inc  13.44 $ 963.647  Millions$ 71.710  Millions
Precipio inc   13.38 $ 27.762  Millions$ 2.075  Millions
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Biodesix Inc   11.45 $ 105.212  Millions$ 9.192  Millions
Gossamer Bio Inc   11.37 $ 78.423  Millions$ 6.896  Millions
Icu Medical Inc  11.32 $ 2,183.556  Millions$ 192.845  Millions
Mannkind Corporation  10.97 $ 413.370  Millions$ 37.686  Millions
Lensar Inc   10.64 $ 60.079  Millions$ 5.645  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Voyager Therapeutics Inc   9.84 $ 25.108  Millions$ 2.551  Millions
Myomo Inc   9.66 $ 47.775  Millions$ 4.947  Millions
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Co diagnostics Inc   9.12 $ 0.859  Millions$ 0.094  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Lexicon Pharmaceuticals Inc   8.77 $ 38.537  Millions$ 4.396  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Avita Medical Inc   8.65 $ 84.683  Millions$ 9.795  Millions

Date modified: 2026-10-31T17:31:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.